Breadcrumbs Navigation

Home > News & Publications > News and Communications > News

Latest Health News from Duke Medicine News and Communications

 « Previous 10 Page of 29 Next 10 »

New Diagnostic Imaging Techniques Deemed Safe in Simulations

Gamma and neutron imaging offer possible improvements over existing techniques such as X-ray or CT, but their safety is not yet fully understood. Using computer simulations, imaging the liver and breast with gamma or neutron radiation was found to be safe, delivering levels of radiation on par with conventional medical imaging, according to researchers at Duke Medicine.

Registry for Fatal Lung Disease Aims to Speed Improvements in Care

Duke Clinical Research Institute (DCRI) has launched a patient registry to help researchers and clinicians identify, manage and study people who have a progressive lung disease called idiopathic pulmonary fibrosis.

One and Done: New Antibiotic Could Provide Single-Dose Option

In the battle against stubborn skin infections, including methicillin-resistant Staphylococcus aureus (MRSA), a new single-dose antibiotic is as effective as a twice-daily infusion given for up to 10 days, according to a large study led by Duke Medicine researchers.

Implanted Heart Device Linked to Increased Survival

Implantable cardioverter defibrillators (ICDs) are associated with improved survival among heart failure patients whose left ventricles only pump 30 to 35 percent of blood out of the heart with each contraction, according to a study from the Duke Clinical Research Institute.

Prostate cancer drug delivers benefits before chemotherapy

A drug currently used to treat men with late-stage prostate cancer proved effective in stemming disease progression and extending survival in patients who had not yet received chemotherapy, according to results from a large international study that included Duke Cancer Institute researchers.

Newly Identified Brain Cancer Mutation Will Aid Drug Development

A collaborative effort between Duke Medicine researchers and neurosurgeons and scientists in China has produced new genetic insights into a rare and deadly form of childhood and young adult brain cancer called brainstem glioma.

Stopping Statins May Benefit Terminally Ill Patients

People in the late stages of cancer and other terminal illnesses are not only unharmed by discontinuing statins for cholesterol management, they may benefit, according to a study presented Friday by researchers at Duke Medicine representing a national research network.

David Zaas, M.D., Named President of Duke Raleigh Hospital

David W. Zaas, M.D., MBA, has been named president of Duke Raleigh Hospital, effective July 1, 2014.

One Molecule to Block Both Pain and Itch

Duke University researchers have found an antibody that simultaneously blocks the sensations of pain and itching in studies with mice.

Non-Invasive Lithotripsy Leads to More Treatment for Kidney Stones

When it comes to treating kidney stones, less invasive may not always be better, according to new research from Duke Medicine.

 « Previous 10 Page of 29 Next 10 »